These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 8256796)

  • 1. The role of bisphosphonates in the prevention and treatment of osteoporosis.
    Papapoulos SE
    Am J Med; 1993 Nov; 95(5A):48S-52S. PubMed ID: 8256796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current bone mineral density data on bisphosphonates in postmenopausal osteoporosis.
    McClung MR
    Bone; 1996 Nov; 19(5 Suppl):195S-198S. PubMed ID: 8922662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of bisphosphonates in the treatment of osteoporosis.
    Papapoulos SE; Landman JO; Bijvoet OL; Löwik CW; Valkema R; Pauwels EK; Vermeij P
    Bone; 1992; 13 Suppl 1():S41-9. PubMed ID: 1581119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of bisphosphonates against osteoporosis in adult men: a meta-analysis of randomized controlled trials.
    Chen L; Wang G; Zheng F; Zhao H; Li H
    Osteoporos Int; 2015 Sep; 26(9):2355-63. PubMed ID: 25944731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Measurement of bone mineral density is necessary for monitoring of bisphosphonate treatment].
    Soen S
    Clin Calcium; 2011 Jan; 21(1):116-9. PubMed ID: 21187604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long-term bisphosphonate administration and its effect on bone metabolism].
    Hagino H
    Clin Calcium; 2005 Apr; 15(4):643-7. PubMed ID: 15802778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bisphosphonates: preclinical aspects and use in osteoporosis.
    Fleisch HA
    Ann Med; 1997 Feb; 29(1):55-62. PubMed ID: 9073324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bisphosphonates in osteoporosis therapy. Standards and perspectives].
    Reinsdorf S; Habermann B; Hochmuth K; Kurth AA
    Orthopade; 2007 Feb; 36(2):110-7. PubMed ID: 17252258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of bone loss and vertebral fractures in patients with chronic epilepsy--antiepileptic drug and osteoporosis prevention trial.
    Lazzari AA; Dussault PM; Thakore-James M; Gagnon D; Baker E; Davis SA; Houranieh AM
    Epilepsia; 2013 Nov; 54(11):1997-2004. PubMed ID: 24010637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisphosphonates for osteoporosis in people with cystic fibrosis.
    Brenckmann C; Papaioannou A
    Cochrane Database Syst Rev; 2001; (4):CD002010. PubMed ID: 11687132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Present and future of osteoporosis therapy.
    Seeman E; Tsalamandris C; Bass S; Pearce G
    Bone; 1995 Aug; 17(2 Suppl):23S-29S. PubMed ID: 8579894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis.
    Chesnut CH; Skag A; Christiansen C; Recker R; Stakkestad JA; Hoiseth A; Felsenberg D; Huss H; Gilbride J; Schimmer RC; Delmas PD;
    J Bone Miner Res; 2004 Aug; 19(8):1241-9. PubMed ID: 15231010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aging bone and osteoporosis: strategies for preventing fractures in the elderly.
    Ettinger MP
    Arch Intern Med; 2003 Oct; 163(18):2237-46. PubMed ID: 14557222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bisphosphonates and combined treatments osteoporosis].
    Rizzoli R; Ferrari S
    Rev Med Suisse; 2005 Oct; 1(35):2266, 2269-71. PubMed ID: 16268449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between pretreatment bone resorption and vertebral fracture incidence in postmenopausal osteoporotic women treated with risedronate.
    Seibel MJ; Naganathan V; Barton I; Grauer A
    J Bone Miner Res; 2004 Feb; 19(2):323-9. PubMed ID: 14969403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bisphosphonates.
    McClung M
    Arq Bras Endocrinol Metabol; 2006 Aug; 50(4):735-44. PubMed ID: 17117298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical effects of bisphosphonates in involutional osteoporosis.
    Ott SM
    J Bone Miner Res; 1993 Dec; 8 Suppl 2():S597-606. PubMed ID: 8122531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics/pharmacodynamics of bisphosphonates: use for optimisation of intermittent therapy for osteoporosis.
    Cremers SC; Pillai G; Papapoulos SE
    Clin Pharmacokinet; 2005; 44(6):551-70. PubMed ID: 15932344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and Safety of Zoledronic Acid for Treatment of Postmenopausal Osteoporosis: A Meta-Analysis of Randomized Controlled Trials.
    Wang C
    Am J Ther; 2017; 24(5):e544-e552. PubMed ID: 26938765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the bisphosphonate tiludronate on bone resorption, calcium balance, and bone mineral density.
    Ammann P; Rizzoli R; Caverzasio J; Shigematsu T; Slosman D; Bonjour JP
    J Bone Miner Res; 1993 Dec; 8(12):1491-8. PubMed ID: 8304051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.